Nanocarriers for Cancer Therapy and Diagnosis, 3rd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 March 2024) | Viewed by 160
Special Issue Editors
Interests: design and production of inorganic/organic nanosystems for pharmaceutical and food applications; nanobiotechnology and development/characterization of functionalized gold nanoparticles for cancer therapy and diagnosis; delivery systems (nanoparticles, polymeric/gold particle carriers); microencapsulation processes by electrospinning technique
Special Issues, Collections and Topics in MDPI journals
Interests: nanoparticle biocompatibility; nanoparticle/drug cell uptake mechanisms; drug delivery; cancer diagnostics and therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, nanocarriers have attracted a significant amount of attention in various biomedical applications, such as site-specific drug delivery and imaging diagnosis. Nano-sized systems based on polymers, metals, and lipids present a high potential to improve the retention and release of chemotherapeutics in cancer cells and tissues, minimize the associated systemic side effects, and overcome multi-drug resistance. They exhibit distinctive physicochemical characteristics, such as biocompatibility, chemical stability, and a reactive surface. These promising vehicles are expected to overcome the limitations of chemotherapeutic agents, such as a lack of biodistribution as well as poor solubility and stability.
Authors are kindly invited to submit original papers and reviews regarding the potential applications of different types of nanocarriers as drug delivery systems for cancer therapy and diagnosis to be published in this Special Issue of Pharmaceutics.
Dr. Sílvia Castro Coelho
Dr. Manuel A. N. Coelho
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanocarriers
- supramolecular structures
- drug delivery systems
- treatment
- diagnosis
- polymer conjugated
- biomaterials
- biocompatible
Related Special Issues
- Nanocarriers for Cancer Therapy and Diagnosis in Pharmaceutics (12 articles)
- Nanocarriers for Cancer Therapy and Diagnosis, 2nd Edition in Pharmaceutics (10 articles)
